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abstract
Caring for patients with a prosthetic eye can be a challenge to clinicians. 
Regardless of the circumstances leading to eye removal, inspection of the 
underlying tissue should be part of a comprehensive eye exam.  Maintaining 
the overall health of the anophthalmic socket is critical in patient comfort 
and optimal prosthetic fit. Discussions will focus on anophthalmic proce-
dures and preparation of the socket for prosthetic fitting.  Care and man-
agement of the prosthesis and the anophthalmic socket, including associ-
ated ocular tissue disorders will be emphasized.  the article will enhance 
the clinician’s comfort level managing patients wearing ocular prosthesis. 
Key WordS: ocular prosthesis, enucleation, evisceration, exenteration, 
orbital implants
Résumé
Le soin des patients qui ont une prothèse oculaire peut poser un défi aux 
cliniciens. Quelles que soient les circonstances à l’origine de l’ablation de 
l’œil, un examen complet de la vue doit inclure l’inspection des tissus sous-
jacents 
 Il est crucial de maintenir la santé générale de la cavité orbitaire anoph-
talmique pour le confort du patient et l’ajustement optimal de la prothèse. 
Les discussions porteront sur les interventions anophtalmiques et la prépa-
ration de la cavité orbitaire pour l’ajustement de la prothèse. On mettra 
l’accent sur le soin et la prise en charge de la prothèse et de la cavité or-
bitaire anophtalmique, y compris les troubles des tissus oculaires connexes. 
L’article permettra aux cliniciens qui traitent des patients portant une pro-
thèse oculaire de se sentir plus à l’aise.
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BaCKgRound
the need for an ocular prosthetic device knows no boundaries.  the population that can be 
affected by ocular disease or trauma is not dictated by age, sex or race.  Regardless of the mode of 
practice, the clinician will likely see patients who have had an anophthalmic procedure, the vast 
majority of whom will be wearing an ocular prosthesis.  Because complications may arise with 
either the prosthetic eye wear or the anophthalmic socket, it is important for the eyecare provider 
to have a firm understanding of management of these cases, as well as when to make appropriate 
referrals to the ocularist and the ophthalmic surgeon.
SuRgiC aL PRoCEduRES
To understand the complications associated with prosthetic wear, one must first understand 
anophthalmic procedures.   the three main surgical techniques used in the partial or complete 
removal of the eye are evisceration and enucleation, respectively, which are the most common, 
and exenteration which is the least common.  Having a grasp of the indications, procedures 
and outcomes involved with each of these surgeries helps to educate patients and to manage 
expectations prior to their meeting with the surgeon.     
enucleation involves the complete removal of the globe, along with a portion of the optic 
nerve, while maintaining the surrounding orbital tissue.  this provides the surgeon with a large, 
intact histological specimen for review, which is particularly important for patients with a known 
intraocular malignancy in which non-surgical treatment options have either failed or are not an 
option and in which the eye cannot be preserved.1  Intraocular tumors have become the primary 
indication for enucleation and would include, but are not limited to, retinoblastomas and uveal 
melanomas.1,2,3,4,5,6 For patients presenting with phthisical eyes of unknown etiology but which 
require removal of the eye, enucleation would once again be the procedure of choice.1  In these 
cases, it is assumed an underlying malignancy may have caused the degeneration, requiring entire 
removal of the globe.   Other indications for enucleation include severely traumatized eyes5 which 
may be at risk for sympathetic ophthalmia.  early enucleation is a point of contention amongst 
eye care providers because of the infrequent incidence of sympathetic ophthalmia, ranging from 
0.001% to 2.0% of traumatized eyes5, as well as the uveitis management options available.5,7,8,9,10 
While traditionally enucleation would be the anophthalmic procedure of choice in sympathetic 
ophthalmia, some studies are finding that evisceration may also be a viable option.8,9  Patients 
with chronic pain due to end stage neovascular glaucoma or chronic uveitis may undergo either 
enucleation or evisceration. 
On an outpatient or inpatient basis, the enucleation procedure is usually performed under 
general anesthesia, but can be performed under local anesthesia with a retrobulbar block alone 
in warranted cases.5,11 After the conjunctiva and tenon’s capsule are dissected, the extra ocular 
muscles are tagged with a stitch and transected from the globe, and the optic nerve is severed, 
allowing for removal of the intact globe.  to increase the chance of complete removal of the known 
or suspected cancerous tissues, a large portion of the optic nerve is usually removed.5  there is 
a risk of ptosis and extra ocular muscle damage during enucleation because the optic nerve is 
transected near the orbital apex. 
due to so much of the natural orbital volume being lost, an orbital implant is then introduced 
into the remaining space via a transducer.  the extra ocular muscles are reattached to the orbital 
implant and tenon’s capsule and the conjunctiva sutured.  An antibiotic ointment is instilled and a 
conformer, which helps maintain the conjunctival space, is then placed over the tissue.  the area is 
then pressure patched for 24-48 hours.5,11 Appropriate analgesics are prescribed for patients, who 
typically will encounter some pain and headache for the first few days.  Once the pressure patch is 
removed, an antibiotic or antibiotic/steroid combination ointment is usually applied twice a day 
for one week.5,11  At one week post-surgery, the conformer is briefly removed for inspection of the 
remaining ocular tissue for signs of infection and for assurance of proper healing.  
evisceration differs from enucleation in that it involves the surgical removal of the contents 
within the globe, while preserving the sclera, extraocular muscles and optic nerve.  Indications 
for evisceration typically include blind, painful eyes found in such cases as chronic uveitis or 
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neovascular glaucoma, as well as those with corneal perforation. Important indications with 
evisceration are patients with endophthalmitis requiring anophthalmic surgery.  there is 
decreased risk of spreading the infectious material through the dura into the intracranial spaces 
since so much of the orbital tissue remains intact during this procedure.  Currently there is 
debate on whether enucleation can also be performed in these situations, particularly since the 
literature suggests an increased risk of sympathetic ophthalmia following evisceration.12 However, 
evisceration continues to be the procedure of choice among surgeons in the majority of these 
cases.6
the evisceration procedure involves an incision near the limbus, with the cornea either 
removed or flapped, after which the surgeon removes the inner contents of the eye through the 
use of an evisceration spoon.  the internal aspect of the sclera is cauterized and treated with 
absolute alcohol to denature any residual proteins, decreasing the risk of sympathetic ophthalmia. 
As with enucleation, the lost orbital volume is replaced with an orbital implant and the sclera 
and conjunctiva are then sutured.  unlike enucleation, there is no need for extra ocular muscle 
reattachment because they were left undisturbed.  An antibiotic ointment and a conformer are 
then placed over the area and the eye is pressure patched, with much of the post-operative care 
mimicking that of enucleation.
the short term goals after both enucleation and 
evisceration are deep fornices to hold the conformer and 
eventually the prosthesis, a socket lined with healthy 
conjunctival membranes, and a normal appearance of 
the lid. (Figure 1)  the aforementioned conformer plays 
an important role in the eventual successful fit of the 
prosthesis by not only helping to stabilize the implant 
during the healing process, but by also reducing the 
risk of tissue contracture of an anophthalmic socket. 
typically the conformer is made of either acrylic or 
silicone and is left in the conjunctival fornices for 4-6 
weeks5 helping to maintain the space that will eventually 
accommodate the prosthesis.  
the eventual cosmetic success of the overlying 
prosthesis is also largely due to the orbital implant 
introduced into the socket during enucleation and evisceration.  during surgery, the surgeon can 
use a sizing sphere to determine the appropriate size; typically a 20mm sphere for adults.11,13 the 
appropriate sized sphere helps create tension free closure of tenon’s capsule and conjunctiva,11 
minimizing complications post operatively.   In addition to replacing the lost volume occurring 
during surgery, an orbital implant maintains the orbital structure and reduces scar formation. 
the implant either directly or indirectly helps to impart movement to the overlying prosthesis, as 
is the case with enucleation and evisceration respectively, or therefore contributes to the ultimate 
goal of having a prosthetic eye that looks and moves similarly to the contralateral eye. 
exenteration is a procedure involving removal all of the tissues within the socket and the entire 
orbit, typically including the conjunctiva, globe, orbital fat, part or all of the lids and sometimes 
a portion of the bony orbit. this most radical of procedures is reserved for patients with large, 
highly invasive orbital tumors which may have originated from within the orbit or from the 
surrounding orbital structures.14 these tumors can be highly destructive, and may have the 
capacity to extend into the intracranial spaces, proving eventually fatal for patients.  Many of these 
patients have a history of malignant tumors of the eye lids, often squamous cell carcinomas and 
basal cell carcinomas15,16,17,18  as well as other highly invasive tumors of the conjunctiva, intraocular 
structures and orbit14 including intraocular malignant melanomas that have extended outside of 
the globe and which may not have responded to non-surgical treatment options such as radiation 
and chemotherapy.1,19 
Figure 1. Healthy anophthalmic socket
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Patients who have undergone exenteration 
often require long term use of a combination 
antibiotic and steroid ointment, as well as long 
term analgesics for management of chronic 
orbital pain.  depending on the extent of tissue 
and bony areas removed, there may be long-
term complications of sinusitis, ear problems, 
orbital cyst ingrowth, infection and malignancy 
recurrence.  there is also the strong possibility 
of psychosocial issues that go along with losing 
such a large, obvious portion of the face.  Some 
patients will decide to use a facial prosthesis but 
many find the facial adhesive used to be highly 
irritating and often discontinue use.  there 
have been some strides made with the use of 
titanium osseo integrated implants to which 
the prosthesis is attached by magnets or clips.15 
Another alternative that patients may opt for is 
the spectacle mounted facial prosthesis. (Figure 
2)  Overall the use of a facial prosthesis is limited, 
with most patients preferring to patch the area15 
and also because of the mortality rate associated 
with recurrence of the malignancy. 
oRBitaL iMPL antS
Orbital implants are typically made of either 
non-porous or porous materials. (Figure 3)  Non-
porous alloplastic implants can be comprised 
of varied inert materials, including the more 
commonly used silicone and polymethyl 
methacrylate (PMMA).6  these materials are 
made into solid, spherical implants that are 
well tolerated, have a low extrusion risk and 
are a good choice for implants that will not be 
integrated, or pegged.   these materials are 
especially important for patients who have had 
infections in which porous implants are no 
longer an option.  to decrease the risk of implant 
migration and to improve motility, the implant 
can be wrapped in a material such as donor 
sclera, providing the option of direct extra ocular 
muscle attachments, depending on the surgery 
performed.
Porous materials, also known as biocompatible 
or biointegrated materials are now more 
commonly used as the initial implant material 
with porous polyethylene, hydroxyapatite and 
aluminum oxide being the most common.6,11,20,21 
due to the porous nature of these materials, 
fibrovascular ingrowth occurs, allowing for 
improved implant stability as well as decreasing 
rejection risk.  Porous polyethylene is a smoother, 
softer material to which the extra ocular muscles 
can be directly attached during enucleation.5,13 
In contrast, hydroxyapatite creates a rough, 
abrasive surface.  to protect the overlying 
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Figure 2. Spectacle mounted prosthesis. 
Figure 3. Various	orbital	implant	materials.	a)	
polymethyl	methacrylate	(PMMA)	,	b)	porous	
polyethylene),	C)	hydroxyapatite		
a
b
c
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tissue and to serve as a scaffold for reattachment of 
the extraocular muscles, the hydroxyapatite implant 
is wrapped in materials ranging from donor sclera or 
autologous tissue to synthetic vicryl or polyglactin 
mesh.5,21  Aluminum oxide as an implant material is 
gaining popularity due to its relative lower cost, as well 
as suggested excellent biocompatibility.21 
the use of a porous orbital implant allows for the 
optional integration of the implant with the overlying 
prosthesis by incorporating a peg. (Figure 4)  this 
involves an additional procedure performed typically 6 
months or more after the initial anophthlamic surgery.5,21 
A fairly quick procedure done under local anesthesia, the 
surgeon will open the conjunctiva and use a specialized 
tool to bore a hole into the implant.  A sleeve is then placed into the opening to serve as a docking 
station for the peg to sit.  Afterwards, the ocularist will modify the posterior portion of the patient’s 
prosthesis.  The goal is to have the peg sit flush with the implant offering the possibility of a better 
range of movement of the overlying prosthesis.  Pegging of the orbital implant also helps decrease 
the weight on the lower lid, decreasing the chance of lid sagging.  Aside from having an additional 
surgical procedure, disadvantages include the risk of infection and chronic discharge from implant 
exposure, as well aberrant movement of the prosthesis secondary to improper peg placement. 
there are studies being conducted looking at using pegs from the initial onset of anophthalmic 
surgery, as well as exploring quasi-integrated orbital implant designs in which the posterior 
prosthesis combines with the anterior portion of the orbital implant in a “lock and key” fashion.21
FaBRiC ation/C aRE oF oCuL aR PRoSthESiS
After the wound has healed, approximately six to eight weeks after surgery, an ocular 
prosthesis can be fitted.22, 23  A prosthetic device 
can be fabricated in two forms, a scleral shell or a 
full thickness prosthesis.  A scleral shell is fit over a 
phthisical eye and a full thickness prosthesis is fit over 
the anophthalmic socket.24 (Figure 5, 6)  the patient 
should be reassured that this is a pain free process.  
The time to produce a custom fit prosthetic device will 
be dependent upon the number of modifications that 
need to be made.  An average time is about one week.
Prosthetic devices can be fit either from a stock set 
of pre-fabricated eyes or can be custom made.  Ideally, 
a custom made prosthetic eye is preferred to increase 
stability and aid in movement as the contour of the 
anophthalmic socket is taken into consideration.25 
there are various materials and methods used in 
the fabrication of a prosthetic device.  the materials 
used today vary from the 
prosthetic device of the past. 
Glass, although still used in 
some areas of europe, has 
given way to more durable 
materials, s u c h  a s  p o l y 
m e t h y l - m e t h a c r y l a t e 
which is chosen for its 
durability, biocompatibility, 
availability and cost.24,25 the 
fitting method chosen is at 
Figure 4. Peg
Figure 6. Ocular prosthesis: right eye. Note matching iris color and 
scleral hue.
Figure 5. Ocular prosthesis made from 
acrylic 
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the discretion of the ocularist.  One of the most common fitting 
techniques is the impression fitting.  
The impression fitting method involves injecting alginate 
material directly into the patient’s orbit using an impression 
tray.24,26 When the substance hardens, it is removed from the 
orbit and then can be adjusted to form the front surface of the 
device using wax. the iris and pupil are then positioned taking 
into account the appearance of the fellow eye.  the mold is 
then filled with methyl-methacrylate resin that is liquid acrylic. 
Various instruments are used to eliminate the formation of air 
pockets within the plastic.  the mold is then heat treated to 
harden the liquid.  After this stage, the device is hand painted 
to reflect the unaffected eye.26   Although fabrication techniques 
vary, a prosthesis that is customized is preferred over stock eyes 
that have not been modified in any way.  Improvement in comfort 
and cosmesis can be achieved as each anophthalmic socket is 
unique.27 (Figures 7, 8, 9)  
Regardless of the method used to create the prosthetic device, 
at each eye exam, the device should be removed from the patient’s 
socket and inspected for defects.  Removal of the prosthetic device 
is similar in fashion to the removal of a hard contact lens.  A 
suction device, typically larger than that used with a hard contact 
lens, can be used to insert and remove the device easily.  In the 
event that a suction device is unavailable, the practitioner, as well 
as the patient, should be comfortable with digital manipulation 
of the prosthesis.25   When using the fingers for removal, the 
prosthesis should be pushed up over the lower eyelid.  this will 
allow the device to slide out from the bottom.  Conversely, when 
inserting the device, the top should be inserted first by pushing up 
under the upper eyelid and sliding the lower part under the lower 
eyelid.  the superior portion of the prosthesis is typically thicker 
and larger than the lower portion to aid in maintaining superior 
lid position and can also help with orientation during insertion.27  
General eye care for the patient wearing a prosthetic device 
requires a detailed history of the patient’s wearing habits 
and how often and in what manner the device is removed and 
cleaned.  the practitioner should ask how old the current device 
is and how often he/she sees the ocularist.  A general guide for 
prosthesis replacement is approximately every five years to 
accommodate for changes to the socket.23   It is recommended that 
patient should see the ocularist every six months for polishing 
and adjustments to the device at least annually.23,24
To ensure a comfortable fit, inspection of the prosthesis is 
important.  the device should be smooth and free of sharp 
edges.  If the device does not feel smooth, it can be washed with 
soap and water or gas permeable contact lens solution.   If it 
continues to feel rough, then the device likely requires polishing, 
contouring or replacement.23  Polishing of the ocular prosthesis, 
unlike polishing of a gas permeable contact lens, cannot be done 
in office and requires a referral to the ocularist.  Contouring to 
ensure proper fitting in the changing socket requires specialized 
equipment and also requires the ocularist’s expertise.23   (Figures 
10, 11)
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Figure 7. Cast used to make custom prosthesis.
Figure 8. Use of Carver press to remove air from 
custom prosthesis prior to hardening.
Figure 9. Custom prosthesis after curing process 
upon removal from mold.
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In addition to inspection of the prosthetic device, 
the patient should be questioned regarding care of the 
device.  Because ocular prosthetics are custom made, 
care is custom as well. What may be standard for one 
patient could be completely different for another. the 
patient should limit the removal of the prosthesis. 
Removing the device too often can lead to increased 
mucous production and irritation of the orbital tissue. 
the device should be left in place and only removed 
for cleaning approximately once per month.22,23  the 
recommendation for cleaning the prosthesis will be 
dependent upon the mucous and protein deposition. 
the prosthesis can be cleaned with soap and water, 
baby shampoo and water, or gas permeable contact 
lens cleaner.23, 24   
CoMPLiC ationS 
In addition to inspecting the device, it is important 
for the eye care provider to inspect the ocular tissue for 
pathology.  the most common ocular tissue disorders 
encountered include discharge, dry eye, discomfort, 
implant exposure, pain, ptosis, lid laxity, expulsion, 
adhesions and problems associated with the peg.28
diSChaRgE  
discharge can be caused by mechanical irritation or 
infection.  In a study conducted by Pine, et al. 93% of 
prosthetic eye wearers reported watering, discharge 
and crusting at some time during prosthesis wear 
with 60% reporting these symptoms daily.29  Just as 
would be done for a patient with a seeing eye, the 
color of the mucous is important. A white, stringy 
discharge typically represents mechanical irritation and/or allergy.  Inspect the tissue for signs of 
giant papillary conjunctivitis.  Alford recommends prednisolone acetate 1% three times a day for 
fourteen days for advanced cases and cromolyn sodium or topical NSAIds for less severe cases.22 
to reduce the incidence of recurrence, question the patient about his/her cleaning habits and 
recommend alternatives. discuss the use of lubricant drops and determine the last time the device 
was professionally polished.
the presence of green or yellow discharge in conjunction with red orbital tissue with or 
without an odor can signify an infection.  A course of topical antibiotics should be initiated while 
recalcitrant cases should be cultured.  the fellow eye should always be examined with or without 
suspected infection.  As with any infection or inflammation, treat appropriately with drops and/or 
ophthalmic ointments to combat the response and consider having the device polished.
dRy EyE
dry eye is a common symptom among prosthesis wearers.  Recommendations for treatment 
will be dependent on the severity of the patient’s symptoms.  A mild dry eye can be treated with 
viscous ocular lubricants three to four times a day.  Just as with the sighted dry eye patient, a 
lubricant with longer lasting power may be needed.  In that case, bland ophthalmic ointment 
or silicone oil should be used.  Bland ophthalmic ointment can be placed in the upper or lower 
cul-de-sac.  this is determined by patient preference or how shallow the inferior portion of the 
prosthesis fits in the lower orbital area.  If the lower orbital area is shallow, inserting ointment in 
the upper eyelid area may insure the prosthesis does not become displaced by manipulation of the 
lower lid.  Many patients find 100% medical grade silicone oil to be a comfortable lubricant.  It 
lasts longer than the viscous artificial tears, yet is thinner than the ointment.   Silicone oil can be 
easily purchased by the bottle or box online from various companies.
Figure 10.	Modification	of	prosthetic	
device.
Figure 11.	Polishing	the	prosthesis.
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A small sample study concluded that cyclosporine A 0.05%, (Restasis, Allergan), has shown 
subjective improvement in ocular comfort in prosthetic wearers.30  This finding lends itself as a 
possible option for those with dry eye complaints in which conventional artificial tears were not 
successful.  Larger cohort studies are necessary to determine both the long term benefit and cost 
consequence of using cyclosporine A drops in this population.  This finding may be an additional 
benefit if blepharitis and meibomian gland dysfunction are found as these often contribute to dry 
eye.  If after addressing the aforementioned dry eye and/or eyelid findings the patient continues 
to experience symptoms, a professional polish must always be considered.
oCuL aR diSCoMFoRt
Ocular discomfort or pain while wearing the prosthesis can lead to an inability in wearing the 
prosthesis successfully and requires the clinician to observe both the device and the orbital area. 
If there are no defects found in the hardware itself, the orbital tissue in and around the socket 
must be scrutinized; several reasons must be considered including malignancy, systemic disease, 
contracted socket syndrome and implant exposure.  In these cases, a thorough history including 
why the patient lost the eye, details about the ophthalmic surgical history, overall systemic health, 
and wear schedule for the device can aid the clinician in making the proper diagnosis.
If anophthalmia was from a malignancy, then tumor growth or metastasis posterior to the 
implant must be considered.  Systemic disease such as thyroid eye disease may cause the prosthesis 
to not fit into the orbit properly.  Since the patient’s extraocular muscles are typically preserved, 
the implant may be pushed anteriorly causing a shallow orbit and an ill-fitting prosthesis.  In these 
instances, a referral to the patient’s primary care physician or oncologist is in order. 
Contracted socket syndrome can be another cause of 
an improper fit. This syndrome causes the conjunctiva to 
tighten as a result of inflammation and fibrosis.31 this can 
occur if a patient is not wearing the prosthesis as directed or 
as a result of direct trauma, surgical insult, burns, cicatricial 
disease or irradiation.23 Surgical intervention is required in 
these cases.  typically mucous membrane grafting is the 
treatment of choice; however recent studies suggest the 
use of amniotic membranes to reconstruct the orbit, post-
auricular full thickness skin grafts or microvascular radial 
forearm free flaps with successful repair.32,33,34  In addition 
to contracture, adhesions can form within the tissue of a 
patient not wearing the prosthesis properly.  tissue such as 
the eyelids, conjunctiva and puncta may adhere to each other 
making the area unable to hold the prosthesis in place properly and also causing expulsion.  Surgical 
correction of the adhesion will allow for proper refitting of the prosthetic device. (Figure 12)
If pain ensues due to implant exposure, measure the size of the defect.    exposure can occur at 
any time post-anophthalmic surgery and must be looked for at each visit.  It has been noted with 
porous implants, exposure between three and twelve months post-op can be due to poor surgical 
technique, infection, inflammation, inadequate tissue healing or erosion of tissue over the implant 
or pressure from the prosthesis.  exposure after two years was most likely from pressure from 
the prosthetic device and friction from both mechanical and inflammatory sources.13  Jordan also 
noted a 2mm defect found four weeks after surgery that closed spontaneously over a two week 
period.  However, if the tissue surrounding the exposure appears infected or infection is a concern, 
antibiotics drops may be used.  Additionally, alterations in the prosthesis should be considered to 
allow for an improved fit over the affected area.  Defects persisting beyond six to eight weeks 
require a consultation with the surgeon as grafting may be necessary to close the wound.29
Lid CoMPLiC ationS
Ptosis and lid laxity are common problems encountered by this population as well.  Ptosis can 
be alleviated by lifting the superior edge of the prosthesis allowing it to fit under the levator to 
improve lid position.  If this has been done several times or if the prosthesis is not fit properly or 
Figure 12. Adhesion of puncta.
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worn in the appropriate manner, lifting the edge will no longer lift the lid.  In these cases, referral 
to the surgeon should be made for repair.  If the ptosis is suspected to be related to the contracted 
socket, repair of the orbital volume may correct the ptosis in 30% of cases according to Jordan.28 
If the ptosis is due to lid laxity, a study conducted by Mombaerts and Groest,35 suggests that a 
preparatory prosthesis can be used to align the pupils prior to ptosis surgery to alleviate moderate 
to severe ptosis.
PEggEd iMPL antS
There are some problems intrinsic to those fitted with a peg.  Examining the tissue surrounding 
the peg and the peg itself is extremely important in these patients.  It has been estimated that patients 
receiving a free standing polycarbonate peg had a complication rate of approximately 71%.36  Notable 
complications include: pyogenic granuloma at peg site, 
loose pegs, conjunctival overgrowth and peg extrusion. 
If the peg is broken, it will not align properly with the 
posterior surface of the prosthesis and will not stay in 
place or move properly.  Conjunctival tissue may begin 
to grow over the peg causing interference with the flush 
posterior surface of the prosthesis and would need to 
be corrected surgically.  Similarly, the conjunctiva may 
also regress around the peg causing exposure near the 
sleeve making the peg loose and increasing the patient’s 
likelihood of infection.  Any of these processes would 
need referral for surgical evaluation.  (Figure 13)
ConCLuSion
Overall working with anophthalmic patients is 
rewarding when the clinician is comfortable looking for the signs of complications due to underlying 
ocular tissue or socket disorders and device irregularities. to provide the patient with the most 
comprehensive eye care, the most important procedure is removal of the device for inspection of the 
tissue and prosthesis, treat the underlying tissue disorders and/or refer to the appropriate specialist 
be it the ocularist or the surgeon.
Figure 13.	Inflammation	caused	by	peg	
complication.
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